Navigation Links
Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting
Date:12/2/2009

EAST HANOVER, N.J., Dec. 2 /PRNewswire/ -- Novartis announced today that new data, including a late-breaking presentation on Tasigna® (nilotinib) 200 mg capsules in a form of chronic myeloid leukemia, demonstrate the strength of the company's hematology portfolio in advancing the care of patients.

The new data, at the 51st American Society of Hematology (ASH) Annual Meeting and Exposition, highlight the company's current therapies and investigational agents in 195 studies including 39 oral presentations. Data will be presented on Tasigna, Afinitor® (everolimus) tablets, Exjade® (deferasirox) and pipeline agents including PKC412 (midostaurin), LBH589 (panobinostat), BHQ880 and INCB18424, an oral, selective Janus kinase (JAK) inhibitor that was recently added to the oncology pipeline through a licensing agreement.

"Data presented at ASH will demonstrate the vigorous research underway to explore the best treatment approaches for patients with rare blood cancers and conditions," said David Epstein, President and CEO, Novartis Oncology and Novartis Molecular Diagnostics. "We expect these data to lay the groundwork for regulatory submissions and provide a roadmap for the initiation of late-stage and pivotal trials."

The ASH Annual Meeting will feature results from a pivotal head-to-head study comparing the efficacy and safety of Tasigna versus Gleevec® (imatinib mesylate) tablets(*) in adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (Abstract #LBA-1; Tuesday, December 8, 2009 at 7:30 AM CST).

Data from this Phase III clinical trial, ENESTnd (Evaluating Nilotinib Efficacy and Safety in Clinical Trials of Newly Diagnosed Ph+ CML Patients), will show that Tasigna produced faster and deeper responses than Gleevec when used as first-line therapy.

Other key presentations at ASH include:


  • '/>"/>

SOURCE Novartis
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine technology :

1. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
2. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
3. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
4. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
5. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
6. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
7. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
8. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
9. DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study
10. FASgen Announces Significant Milestone in Its Cancer Drug Development Program
11. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)...  Sony Biotechnology Inc. ("Sony") today announced the launch of ... sorting chip.  Sony will also be exhibiting its newly rebranded ... Sorter, the EC800 flow cytometer, and new SP6800 Spectral Analyzer ... will be held at the San Diego ... , from May 20 - 22.  The ...
(Date:5/17/2013)... May 17, 2013  TechAtlas Group has announced ... competitive landscape map for the Chronic Kidney Disease ... international companies with drugs and devices currently on ... its sequelae. (Logo:  http://photos.prnewswire.com/prnh/20130517/NE16011LOGO ... , hypertension - renal denervation , diabetic ...
(Date:5/17/2013)... May 17, 2013 Fuse Science, Inc. (OTCQB: DROP), ... that is developing new, patent-pending technologies poised to redefine how ... it will hold a business update teleconference and webcast for ... , 2013 at 4:30 PM ET. Fuse ... host the call and will be joined by ...
Breaking Medicine Technology:Sony Delivers New Technology for Science to CYTO 2013 2TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2
... , CHICAGO, Nov. 30 A ... (CT) receive unindicated and unnecessary additional image acquisition resulting ... presented today at the annual meeting of the Radiological ... responsibility of all physicians who work with ionizing radiation ...
... IOWA CITY, Iowa and ST. LOUIS, Nov. 29 ... for the advanced analysis of pulmonary diseases, and Veran ... interventional oncology therapies, announced the companies have signed a ... endobronchial lung navigation and biopsy system. , "Veran,s ...
Cached Medicine Technology:Unindicated CT Series Result in Unnecessary Radiation Exposure for Patients 2Unindicated CT Series Result in Unnecessary Radiation Exposure for Patients 3VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 2VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 3VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 4
(Date:5/19/2013)... These molecular diagnostics market reports ... Japan, Italy, Germany and France:, ... practice, as well as key economic, regulatory, demographic, ... during the next five years. ,     An ... test formats, detection methodologies, trends in testing automation ...
(Date:5/19/2013)... Amenia, NY (PRWEB) May 19, 2013 ... According to the newest American Veterinary Medical Association ... two-thirds of American dog owners consider their dog a ... owners who had said as much five years earlier. ... total dollar value of the national income dedicated to ...
(Date:5/19/2013)... Vegas Hotel Escapes, the premier ... the launch it's all new vacation packages for the ... 5/19/2013. Consumers traveling to Las Vegas will be pleased ... VegasHotelEscapes.com's website. Travelers will be pleased to know that ... , Vegas Hotel Escapes specializes in helping consumers ...
(Date:5/19/2013)... Passages Malibu, the leading non-12 step, ... this week the launch of a “Sobriety, Health, and ... channels. “We are always looking for new ways ... get feedback regarding sobriety, what’s working for people, and ... the Passages Addiction Treatment Centers located in ...
(Date:5/19/2013)... Florida (PRWEB) May 19, 2013 ... market access, is pleased to unveil a new and ... environment that provides a powerful array of real-time communication ... in the US and abroad. , HE-Xpo is powered ... offer attendees the look and feel of being at ...
Breaking Medicine News(10 mins):Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 2Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 3Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 3
... largest general science conference will be the setting next ... classroom in Rochester. Those presenting at the conference in ... State University, educators from the Rochester school system, and ... how science was taught. That led to adding curriculum ...
... to Improve Health: IOM-NAE Health Data Collegiate Challenge" was ... Academy of Engineering to promote interaction among future health ... harnessing new technologies and data to solve vexing health ... students studying engineering, computer science, and health disciplines to ...
... ten years since the human genetic code was mapped, expectations ... have remained high concerning the promise of genomics research for ... prominent genetic medicine and bioethics experts cautions against the dangers ... and it offers ways to avoid it while still realizing ...
... By Maureen Salamon HealthDay Reporter , THURSDAY, Feb. ... a few weeks early has no discernible impact on babies, ... developmental delays than their full-term peers and those delays may ... from 6,300 term and 1,200 late preterm infants -- those ...
... FL (Feb. 17, 2011) -- The 2nd Annual National Women ... 6 at the Hyatt Regency Clearwater Beach, featuring two of ... country as speakers. Keynote speakers will be ... Department of Surgery Surgeon-in-Chief, The Johns Hopkins Hospital, and Nancy ...
... , THURSDAY, Feb. 17 (HealthDay News) -- Some 709,000 youngsters ... beer, liquor and other alcoholic beverages, a new federal study ... underage drinkers aren,t just getting a friend to buy a ... family liquor cabinet. Some are getting the alcohol directly from ...
Cached Medicine News:Health News:Mayo researchers, Rochester educators, students to present at science conference 2Health News:IOM and NAE launch collegiate challenge aimed at solving health problems 2Health News:Promise of genomics research needs a realistic view 2Health News:Delivery Even a Bit Early May Mean Developmental Delays 2Health News:Delivery Even a Bit Early May Mean Developmental Delays 3Health News:National career symposium offers strategic advice to attract, advance women in surgery 2Health News:Many Kids Who Drink Get Liquor From Home: Report 2Health News:Many Kids Who Drink Get Liquor From Home: Report 3
West lacrimal cannula blunt tip with side port....
Shahinian lachrymal cannula, blunt tapered with side port....
West lacrimal cannula, blunt tip, 0.3 mm side opening....
The first easy-to use peroxide system offers proven efficacy that's pure and simple. The convenience of a multi-purpose cleaner/rinse in one bottle. Added power of peroxide in the other bottle....
Medicine Products: